These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30393375)

  • 1. Phase I trial of intravenous Ad5CRT in patients with liver metastasis of gastrointestinal cancers.
    Lee SJ; Shin SP; Lee SH; Kang JW; Kook MC; Kim IH; Kim HK
    Cancer Gene Ther; 2019 May; 26(5-6):174-178. PubMed ID: 30393375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.
    Sterman DH; Treat J; Litzky LA; Amin KM; Coonrod L; Molnar-Kimber K; Recio A; Knox L; Wilson JM; Albelda SM; Kaiser LR
    Hum Gene Ther; 1998 May; 9(7):1083-92. PubMed ID: 9607419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model.
    Jeong JS; Lee SW; Hong SH; Lee YJ; Jung HI; Cho KS; Seo HH; Lee SJ; Park S; Song MS; Kim CM; Kim IH
    Clin Cancer Res; 2008 Jan; 14(1):281-90. PubMed ID: 18172280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
    Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM
    Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo reprogramming of human telomerase reverse transcriptase (hTERT) by trans-splicing ribozyme to target tumor cells.
    Lee SJ; Lee SW; Jeong JS; Kim IH
    Methods Mol Biol; 2010; 629():307-21. PubMed ID: 20387158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial.
    Sung MW; Yeh HC; Thung SN; Schwartz ME; Mandeli JP; Chen SH; Woo SL
    Mol Ther; 2001 Sep; 4(3):182-91. PubMed ID: 11545608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial.
    Reid T; Galanis E; Abbruzzese J; Sze D; Andrews J; Romel L; Hatfield M; Rubin J; Kirn D
    Gene Ther; 2001 Nov; 8(21):1618-26. PubMed ID: 11895000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer.
    Kubo H; Gardner TA; Wada Y; Koeneman KS; Gotoh A; Yang L; Kao C; Lim SD; Amin MB; Yang H; Black ME; Matsubara S; Nakagawa M; Gillenwater JY; Zhau HE; Chung LW
    Hum Gene Ther; 2003 Feb; 14(3):227-41. PubMed ID: 12639303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma.
    Ji N; Weng D; Liu C; Gu Z; Chen S; Guo Y; Fan Z; Wang X; Chen J; Zhao Y; Zhou J; Wang J; Ma D; Li N
    Oncotarget; 2016 Jan; 7(4):4369-78. PubMed ID: 26716896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O; Morris JC
    Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase.
    Mizuguchi H; Hayakawa T
    Cancer Gene Ther; 2002 Mar; 9(3):236-42. PubMed ID: 11896439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
    Xu F; Li S; Li XL; Guo Y; Zou BY; Xu R; Liao H; Zhao HY; Zhang Y; Guan ZZ; Zhang L
    Cancer Gene Ther; 2009 Sep; 16(9):723-30. PubMed ID: 19363470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model.
    Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral-mediated herpes simplex virus thymidine kinase gene transfer: regression of hepatic metastasis of pancreatic tumors.
    Block A; Chen SH; Kosai K; Finegold M; Woo SL
    Pancreas; 1997 Jul; 15(1):25-34. PubMed ID: 9211489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant adenovirus infection suppresses hTERT expression through virus-associated RNA-mediated induction of type 1 interferon.
    Lee CH; Kim HW; Kim T; Lee SW
    Biochem Biophys Res Commun; 2015 Mar; 458(4):830-5. PubMed ID: 25689720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer.
    Freytag SO; Stricker H; Pegg J; Paielli D; Pradhan DG; Peabody J; DePeralta-Venturina M; Xia X; Brown S; Lu M; Kim JH
    Cancer Res; 2003 Nov; 63(21):7497-506. PubMed ID: 14612551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression of herpes simplex virus thymidine kinase and Escherichia coli nitroreductase by an hTERT-driven adenovirus vector in breast cancer cells results in additive anti-tumor effects.
    Yu B; Zhang Y; Zhan Y; Zha X; Wu Y; Zhang X; Dong Q; Kong W; Yu X
    Oncol Rep; 2011 Jul; 26(1):255-64. PubMed ID: 21573500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
    Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.
    Herman JR; Adler HL; Aguilar-Cordova E; Rojas-Martinez A; Woo S; Timme TL; Wheeler TM; Thompson TC; Scardino PT
    Hum Gene Ther; 1999 May; 10(7):1239-49. PubMed ID: 10340555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir.
    Smitt PS; Driesse M; Wolbers J; Kros M; Avezaat C
    Mol Ther; 2003 Jun; 7(6):851-8. PubMed ID: 12788659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.